Paper 92 - LONG-TERM OUTCOMES IN CHILDREN, ADOLESCENTS, AND YOUNG ADULTS WITH LOCALIZED EWING SARCOMA TREATED WITH IFOSFAMIDE DOSE-INTENSIFICATION

Saturday, November 19, 2022

4:08 PM – 4:16 PM

Author(s)

Christine Goodboy, MD

Attending Physician
Children's Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
Viswatej Avutu, MD

Assistant Attending
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Julia Glade Bender, MD

Vice Chair for Clinical Research, Department of Pediatrics
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Mark A. Dickson, MD

Associate Attending Physician
Memorial Sloan Kettering Cancer Center
New York, New York, United States
FD

Filemon S. Dela Cruz, MD

Memorial Sloan Kettering Cancer Center
New York, New York, United States
Tara O'Donohue, MD (she/her/hers)

Assistant Attending
Memorial Sloan Kettering Cancer Center
New York, New York, United States
William D. Tap, MD

Chief, Sarcoma Medical Oncology Service
Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, NY, USA
New York, New York, United States
LW

Leonard Wexler, MD

Memorial Sloan Kettering Cancer Center
New York, New York, United States
Emily K. Slotkin, MD

Assistant Attending
Memorial Sloan Kettering Cancer Center
New York, New York, United States
Paul A. Meyers, MD

Vice Chair, Department of Pediatrics
Memorial Sloan Kettering Cancer Center
New York, New York, United States